Rethinking the Future of Cancer Care

This Financial Times Digital Dialogue, held in partnership with the European Federation of Pharmaceutical Industries and Associations (EFPIA) Oncology Platform and a sounding board of more than 20 stakeholders, brought together the cancer community, including patients, healthcare policymakers, leading physicians, healthcare providers and payers to discuss the many innovative ways that are emerging to make cancer care more resilient, and the vital policy approaches that are needed to drive innovation and improve access.

Resilience

At a time of heightened geopolitical and economic uncertainty and rising costs, how can we redesign cancer care to make it more robust? How can smart investments strengthen the resilience and sustainability of our healthcare systems while meeting increased demand for healthcare?

Challenges

What are the main challenges to be addressed in order to ‘spend smarter’ and deliver better outcomes for patients? 

Innovations

What are the examples of innovations and best practice that have yielded improved outcomes for patients and society? What can be done to support their scale up across Europe?

Solutions

What needs to be done to address these issues, and what should be the role of policymakers at national and EU level, and non-governmental actors? 

Understand

The big picture, not just the individual strands of the business you work in

Connect

And build relationships with some of the biggest names in your industry

Discover

New approaches and strategies to help win market share

FT Live Digital Dialogues - fully digital one hour event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice